OpSens

Medical News

OpSens Broadcasts SavvyWire™ at CRT Convention

March 1, 2023

Quebec Metropolis, Quebec, February 28, 2023 – OpSens Inc. (“OpSens” or the “Firm”) (TSX:OPS) (OTCQX:OPSSF), a medical machine cardiology-focused firm delivering...

4 causes to query “new technology” monoclonal antibody Alzheimer’s medication resembling aducanumab (Aduhelm), lecanemab (Leqembi), donanemab

September 30, 2023

Shane Parrish on Knowledge from Warren Buffett, Guidelines for Higher Considering, Methods to Scale back Blind Spots, The Risks of Psychological Fashions, and Extra (#695)

September 30, 2023

Is Care Navigation the Reply to a Messy U.S. Well being System?

September 30, 2023

New Melancholy Drug Avoids Unlucky Facet Results of Others

September 30, 2023

Mayo Clinic, Phenomix Awarded First Patent for Weight problems Phenotyping

September 30, 2023

Latest Post

4 causes to query “new technology” monoclonal antibody Alzheimer’s medication resembling aducanumab (Aduhelm), lecanemab (Leqembi), donanemab

Shane Parrish on Knowledge from Warren Buffett, Guidelines for Higher Considering, Methods to Scale back Blind Spots, The Risks of Psychological Fashions, and Extra (#695)

Is Care Navigation the Reply to a Messy U.S. Well being System?

New Melancholy Drug Avoids Unlucky Facet Results of Others

Mayo Clinic, Phenomix Awarded First Patent for Weight problems Phenotyping